US 12331058
SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same
granted A61KA61K31/506A61K31/519
Quick answer
US patent 12331058 (SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same) held by CHINA PHARMACEUTICAL UNIVERSITY expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHINA PHARMACEUTICAL UNIVERSITY
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/506, A61K31/519, A61K31/55, A61P